Literature DB >> 2944687

Effect of posture on plasma immunoreactive atrial natriuretic peptide concentrations in man.

L R Solomon, J C Atherton, H Bobinski, R Green.   

Abstract

The effect of changes of posture on plasma atrial natriuretic peptide concentrations and renal function was studied in normal human volunteers. Plasma atrial natriuretic peptide concentrations increased in the supine posture, reached a maximum value after 30-60 min, remained elevated for 4 h and decreased to baseline values on return to the upright posture. Inflation of antishock trousers, which apply positive pressure to the legs and lower abdomen, attenuated the fall in plasma atrial natriuretic peptide concentration in the upright position. In the supine posture there were increases in urine flow rate, sodium, lithium, fractional sodium and fractional lithium clearances. Fractional distal water and sodium excretion, and total distal water and sodium reabsorption, which were estimated by the lithium clearance technique, also increased. Heart rate and systolic and diastolic blood pressures decreased in the supine and increased on return to the upright posture. Inflation of antishock trousers prevented the increase in heart rate in the upright posture. The contribution of haemodynamic factors to the increase in plasma atrial natriuretic peptide concentrations in the supine position and the relationship between this increase and the associated changes in renal function are discussed. However, the contribution of atrial natriuretic peptide to these changes is uncertain.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2944687     DOI: 10.1042/cs0710299

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  10 in total

1.  A comparison of head-down tilt with low-dose infusion of atrial natriuretic peptide in man.

Authors:  M J Allen; V T Ang; D Bennett
Journal:  J Physiol       Date:  1989-03       Impact factor: 5.182

2.  The interaction of plasma renin activity and plasma atrial natriuretic peptide in 21-hydroxylase deficiency patients.

Authors:  C M R Germano; M de Castro; J C Crescencio; L Gallo; J Antunes-Rodrigues; A C Moreira; L L K Elias
Journal:  J Endocrinol Invest       Date:  2005-04       Impact factor: 4.256

Review 3.  Effects of omapatrilat on pharmacodynamic biomarkers of neutral endopeptidase and Angiotensin-converting enzyme activity in humans.

Authors:  O Vesterqvist; R A Reeves
Journal:  Curr Hypertens Rep       Date:  2001-12       Impact factor: 5.369

Review 4.  Atrial natriuretic peptides: clues to their physiological and clinical importance.

Authors:  D R Singer
Journal:  Postgrad Med J       Date:  1987-01       Impact factor: 2.401

5.  Increase in plasma concentrations of cardiodilatin (amino terminal pro-atrial natriuretic peptide) in cardiac failure and during recumbency.

Authors:  L Meleagros; J S Gibbs; M A Ghatei; S R Bloom
Journal:  Br Heart J       Date:  1988-07

6.  Exercise increases the release of atrial natriuretic peptide in heart transplant recipients.

Authors:  J Pepke-Zaba; T W Higenbottam; A Morice; A T Dinh-Xuan; A E Raine; J Wallwork
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

7.  Human atrial natriuretic factor and renin-aldosterone in paracetamol induced fulminant hepatic failure.

Authors:  M Z Panos; J V Anderson; A Forbes; N Payne; J D Slater; L Rees; R Williams
Journal:  Gut       Date:  1991-01       Impact factor: 23.059

8.  Effects of physical exercise and anti-G suit inflation on atrial natriuretic factor plasma level.

Authors:  C Y Guezennec; E Fournier; F X Galen; M Lartigues; F Louisy; J Gutkowska
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1989

9.  The effect of acute ACE inhibition on atrial natriuretic peptide.

Authors:  C J Doorenbos; P van Brummelen
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

10.  Atrial natriuretic peptide (ANP) in patients with chronic renal failure on maintenance haemodialysis.

Authors:  R de Châtel; J Makó; M Tóth; I Barna; R E Lang
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.